Cleared Traditional

K884517 - PATHFINDER(TM) CHLAMYDIA EIA DETECT KIT...

K884517 is the FDA 510(k) clearance for PATHFINDER(TM) CHLAMYDIA EIA DETECT KIT... by Kallestad Diag, A Div. of Erbamont, Inc.. It is a Class 1 Microbiology device (product code LJC) cleared through the Traditional 510(k) pathway after a 34-day FDA review.

K884517 · Kallestad Diag, A Div. of Erbamont, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1988
Decision
34d
Days
Class 1
Risk

K884517 is an FDA 510(k) clearance for the PATHFINDER(TM) CHLAMYDIA EIA DETECT KIT/MODIFIED. Classified as Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group) (product code LJC), Class I - General Controls.

Submitted by Kallestad Diag, A Div. of Erbamont, Inc. (Chaska, US). The FDA issued a Cleared decision on November 30, 1988 after a review of 34 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3120 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Kallestad Diag, A Div. of Erbamont, Inc. devices

Submission Details

510(k) Number K884517 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 27, 1988
Decision Date November 30, 1988
Days to Decision 34 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
68d faster than avg
Panel avg: 102d · This submission: 34d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code LJC Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3120
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LJC Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group)

All 46
Devices cleared under the same product code (LJC) and FDA review panel - the closest regulatory comparables to K884517.
CHLAMYDIAZYME BLOCKING REAGENT
K892371 · Abbott Laboratories · Jun 1989
MICROTRAK CHLAMYDIA EIA
K890196 · Syva Co. · Mar 1989
CHLAMYDIAZYME/COMMANDER INSTRUMENTATION
K885006 · Abbott Laboratories · Dec 1988
KODAK SURECELL CHLAMYDIA TEST KIT
K882923 · Eastman Kodak Company · Nov 1988
PHARMACIA CHLAMYDIA EIA
K882676 · Pharmacia, Inc. · Aug 1988
ABBOTT TESTPACK CHLAMYDIA
K880783 · Abbott Laboratories · Jul 1988